The urology surgical instruments market has witnessed significant expansion in recent years, driven by the marked increase in healthcare expenditure and the development of surgical and healthcare infrastructure. The market has also benefited from the growing global preference for minimally invasive surgical techniques. Expected favorable government initiatives, reimbursement policies in developed economies, and increasing demand for minimally invasive surgeries are expected to further accelerate market growth. However, concerns about potential infections associated with urology surgical instruments remain widespread. The increasing prevalence of urological diseases, such as urinary tract infections (UTIs), prostate cancer, chronic kidney disease (CKD), and benign prostatic hyperplasia (BPH), will continue to drive the market’s vibrancy.
Read more: https://www.fairfieldmarketresearch.com/report/urology-surgical-instruments-market
Key findings of the report
- The urology surgical instruments market reached a valuation beyond $9.8 billion in 2021.
- Widely prevalent conditions such as UTI, CKD, BPH, prostate cancer and urological cancers are driving the demand for urological surgical instruments.
- Sales of consumables and accessories dominate the market.
- North America leads the market based on primary regional analysis.
Increasing cases of kidney disease
Various kidney disorders, including hemolytic uremic syndrome, renal cysts, cystic kidney disease, chronic kidney disease, and lupus nephritis, contribute to the increased incidence of kidney failure. Early diagnosis and prompt medical intervention are crucial in the management of these conditions. End-stage renal disease (ESRD) affects over 500,000 Americans each year, according to a September 2021 paper published in the National Institutes of Health. Age is an important factor influencing the prevalence of CKD, with the highest rate of progression observed in individuals over 60 years of age. The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) reported that over 786,000 people in the United States were affected by ESRD in 2020, with 71% requiring dialysis and 29% needing a kidney transplant. To combat this issue, government assistance through reimbursement and product innovation for low-cost and effective treatments is expected to boost the urology surgical instruments market.
Increasing the number of hospitals investing in endoscopy and laparoscopy facilities
The growing preference for minimally invasive techniques has led to an increasing number of hospitals investing in endoscopy and laparoscopy facilities. Hospitals are expanding existing endoscopy units and acquiring new technology to meet patient demands. Similar trends are seen around the world, with the launch of the new Greater Greater Manchester Modular Endoscopy Unit in Bury by Fairfield General Hospital in January 2021. This facility was created to support the provision of the endoscopy service, which was disrupted by the pandemic. The demand for urology surgical instruments, such as endoscopes and endovision systems, is expected to increase as hospitals invest in modern instruments and expand their units. The creation of new centers further contributes to the progress of the market.
The high cost of urology endoscopes and endoscopy systems, especially in price-sensitive markets such as Asia Pacific, hinders market growth. Healthcare providers, especially in developing countries such as Brazil and Mexico, often lack the financial capacity to invest in expensive and complex equipment. Additionally, training staff members in the proper use and maintenance of urology surgical instruments is essential to prevent cross-contamination and infections. However, the costs associated with the maintenance and reprocessing of these instruments can increase. Consequently, doctors and consumers often choose less expensive alternative treatments. Lack of supportive FDA reviews for medical devices also poses a measurable threat to the expansion of the urology surgical instruments market.
Overview of key segments
Consumables and accessories Dominant category
In the global urology surgical instruments market, the consumables and accessories segment holds the largest share of revenue. This segment is driven by frequent use and availability. As urological procedures increase globally, the demand for consumables and accessories is expected to increase. The segment includes stone baskets/retrieval devices, fluid lavage tools, stents, forceps and needle holders, connecting tubes, distal attachments, clamps, drainage bags, clamps, biopsy tools, catheters, dilation sets, ureteral access sheaths , guide wires, surgical dissectors and other related items.
Endoscopes as an important product category
Endoscopes represent the second largest product category in the urology surgical instruments market. The growing need for less invasive approaches to diagnostic and therapeutic procedures is driving the demand for endoscopes. Factors contributing to increased demand include investments by private players, public sector grants or funds, increasing number of hospitals and clinics, and introduction of technologically advanced products.
CKD remains a prominent category
The CKD segment holds the largest market share among applications and is expected to continue to grow as the leading application category. This can be attributed to the increasing prevalence of CKD, the expansion of clinical trials for noninvasive therapies, and global government initiatives. Early identification and therapy are essential in managing CKD and preventing further kidney damage. Failure to receive treatment can lead to end-stage renal disease (ESRD), a life-threatening condition. Consequently, the demand for urological interventions to control kidney diseases is driven by their increasing occurrence and associated health consequences.
Growth opportunities across regions
North American primate intact with rising cases of urological cancer
North America is projected to account for the largest revenue share in the urology surgical instruments market during the forecast period. Factors such as the growth of the geriatric population in the US and Canada, increasing rates of cancer and urological disorders, the purchase of urological equipment by hospitals, the increase in the number of urologists, favorable reimbursement conditions, and the increase in health care expenditures for urological disorders contribute to this market. dominance. The United States, in particular, stands out as a leading market due to the high prevalence of urological disorders, increased urological procedures, increased hospital spending on urological surgical instruments, and the continuous introduction of technologically advanced products. The availability of reimbursement for urological surgeries is expected to further increase the volume of urological procedures performed and the demand for related instruments.
Stable market in Asia Pacific
The urology surgical instruments market in Asia Pacific is expected to experience steady revenue growth throughout the forecast period, driven by rising discretionary income. The market will benefit significantly from the expansion of free trade agreements between Asian and Western countries, increased government spending on urological care, and stricter regulations governing invasive devices. Improved healthcare infrastructure in countries such as China and India, along with rapid expansion of medical tourism, will also support market growth. Numerous public and private institutions in China, Australia, New Zealand, Malaysia, Singapore, Japan, Indonesia and India are investing in new urology technology to meet the growing demand for urological procedures.
Major Companies in the Global Urology Surgical Instruments Market
Key players in the urology surgical instruments market include Olympus Corporation, Coloplast Group, Richard Wolf GmbH, KARL STORZ, Cook, Boston Scientific Corporation, Medtronic, Teleflex Incorporated and Stryker.
In conclusion, the urology surgical instruments market is poised for continued growth due to rising healthcare expenditure, increasing preference for minimally invasive techniques, and prevalence of urological diseases. However, challenges such as premium pricing and lack of supportive FDA reviews need to be addressed. The predominance of consumables and accessories, along with the importance of the CKD segment, indicates significant opportunities for market players. North America leads the market, while Asia Pacific exhibits steady growth potential. As the market expands, advances in technology, cost-effective solutions, and increased awareness of urologic conditions will contribute to improved patient outcomes.
The urology surgical instruments market is witnessing significant growth driven by healthcare expenditure, development of surgical infrastructure and preference for minimally invasive techniques. Increasing cases of kidney diseases and increased investment in endoscopy and laparoscopy facilities are the main growth drivers. However, premium pricing and regulatory challenges pose barriers to market expansion. Consumables and accessories dominate the market, with endoscopes being another important product category. Chronic kidney disease remains a prominent application segment. North America leads the market, while Asia Pacific exhibits steady growth potential. Key players in the market include Olympus Corporation, Coloplast Group, Richard Wolf GmbH, KARL STORZ, Cook, Boston Scientific Corporation, Medtronic, Teleflex Incorporated and Stryker.
Visit our blog: https://www.fairfieldmarketresearch.com/blog/the-global-last-mile-delivery-market-a-comprehensively-insightful-overview
For further details, please visit www.fairfieldmarketresearch.com
Fairfield Market Research
UK +44 (0)20 30025888
USA (toll free) +1 (844) 3829746
Email: [email protected]